NEXIEN BIOPHARMA, INC. reports

Company location: Glendale, CO
Fiscal year end: 30 June

NEXIEN BIOPHARMA, INC. has filed 201 SEC EDGAR filings since 14 Nov 2014

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 26-50 of 201 matching filings.

Per page

25

Current page

2

4

PRIMARY DOCUMENT

Filing date: 17 Jan 2023
Reporting date: 17 Jan 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 17 Jan 2023
Reporting date: 17 Jan 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 000-55320

10-Q filing

Filing date: 09 Nov 2022
Reporting date: 30 Sep 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 18 Oct 2022
Reporting date: 17 Oct 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 18 Oct 2022
Reporting date: 17 Oct 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 18 Oct 2022
Reporting date: 17 Oct 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

10-K File 000-55320

10-K filing

Filing date: 28 Sep 2022
Reporting date: 30 Jun 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 15 Sep 2022
Reporting date: 20 Apr 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 14 Sep 2022
Reporting date: 27 Jul 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 14 Sep 2022
Reporting date: 20 Apr 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 000-55320

10-Q filing

Filing date: 12 May 2022
Reporting date: 31 Mar 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 000-55320

10-Q filing

Filing date: 08 Feb 2022
Reporting date: 31 Dec 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 31 Jan 2022
Reporting date: 27 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 31 Jan 2022
Reporting date: 27 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-55320

8-K filing

Filing date: 21 Jan 2022
Reporting date: 18 Jan 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 29 Nov 2021
Reporting date: 29 Nov 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 29 Nov 2021
Reporting date: 29 Nov 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 000-55320

10-Q filing

Filing date: 22 Nov 2021
Reporting date: 30 Sep 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-K File 000-55320

10-K filing

Filing date: 12 Oct 2021
Reporting date: 30 Jun 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

NT 10-K File 000-55320

NT 10-K filing

Filing date: 28 Sep 2021
Reporting date: 30 Jun 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 07 Jun 2021
Reporting date: 07 Jun 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 000-55320

10-Q filing

Filing date: 05 May 2021
Reporting date: 31 Mar 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

4 filing

Filing date: 05 Apr 2021
Reporting date: 01 Apr 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 05 Apr 2021
Reporting date: 01 Apr 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 000-55320

10-Q filing

Filing date: 11 Feb 2021
Reporting date: 31 Dec 2020
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .